Clinical Trial Update: Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inhaled xenon for reducing brain injury after aneurysmal subarachnoid hemorrhage is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Cerebral Infarction
• Cerebral Ischemia

Drugs mentioned

• Xenon (xenon)

Snippet

Sponsor: Turku University Hospital | Conditions: Subarachnoid Hemorrhage, Aneurysmal, Cerebral Injury | Phase 2 | Status: RECRUITING